2020
DOI: 10.1007/s10856-020-06364-y
|View full text |Cite
|
Sign up to set email alerts
|

Scaffolds and coatings for bone regeneration

Abstract: Bone tissue has an astonishing self-healing capacity yet only for non-critical size defects (<6 mm) and clinical intervention is needed for critical-size defects and beyond that along with non-union bone fractures and bone defects larger than critical size represent a major healthcare problem. Autografts are, still, being used as preferred to treat large bone defects. Mostly, due to the presence of living differentiated and progenitor cells, its osteogenic, osteoinductive and osteoconductive properties that al… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
71
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 90 publications
(71 citation statements)
references
References 170 publications
(183 reference statements)
0
71
0
Order By: Relevance
“…Potential approaches include the use of improved scaffolds and addition of exogenous growth factors; however, the most difficult aspect of this equation is to renew or revitalize the host cells locally or provide additional cells of the MSC-osteoblast cell lineage, the endothelial cell lineage, and other cells that could engraft or provide critical signaling mechanisms to enhance bone healing (Prockop, 2009 ). Although there has been extensive literature on the use of bone substitutes, novel scaffolds and growth factors, studies focused on providing or augmenting the deficient cellular components that are needed for bone healing have received less attention (Bravo et al, 2013 ; Park et al, 2018 ; Marongiu et al, 2020 ; Pereira et al, 2020 ).…”
Section: Introductionmentioning
confidence: 99%
“…Potential approaches include the use of improved scaffolds and addition of exogenous growth factors; however, the most difficult aspect of this equation is to renew or revitalize the host cells locally or provide additional cells of the MSC-osteoblast cell lineage, the endothelial cell lineage, and other cells that could engraft or provide critical signaling mechanisms to enhance bone healing (Prockop, 2009 ). Although there has been extensive literature on the use of bone substitutes, novel scaffolds and growth factors, studies focused on providing or augmenting the deficient cellular components that are needed for bone healing have received less attention (Bravo et al, 2013 ; Park et al, 2018 ; Marongiu et al, 2020 ; Pereira et al, 2020 ).…”
Section: Introductionmentioning
confidence: 99%
“…Table 3. Requirements for the design of scaffolds in bone tissue engineering [141][142][143][144][145][146][147].…”
Section: Development Of Electrospun Polymers Reinforced With Mg-basedmentioning
confidence: 99%
“…[ 5 ] Additional materials are required for treating bone defects with a high risk of nonunion (>6 mm in diameter) to re‐establish the functions of the original tissues. [ 6 ] The current gold standard of grafting with autologous bone is faced with the limited availability of donor sites as well as secondary damage or infection. [ 7,8 ] Conversely, the use of allogenic or xenogenic transplants may result in adverse immune responses and disease transmission.…”
Section: Introductionmentioning
confidence: 99%